How many drugs treat Diabetic gastroparesis?

Drug Landscape tracks 3 marketed treatments for Diabetic gastroparesis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/diabetic-gastroparesis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Diabetic gastroparesis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diabetic gastroparesis (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Diabetic gastroparesis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Reglan	METOCLOPRAMIDE	Hikma	Dopamine-2 Receptor Antagonist	D(3) dopamine receptor	1979-01-01
Reglan	Metoclopramide Hydrochloride	Hikma	Prokinetic agent	Acetylcholine receptor sensitization; dopamine antagonism (implied)	1979-01-01
Metaclopramide	Metaclopramide	Institute of Liver and Biliary Sciences, India		Aldehyde oxidase, Myeloperoxidase, Solute carrier family 22 member 1

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Hikma · 2 drugs in Diabetic gastroparesis
Institute of Liver and Biliary Sciences, India · 1 drug in Diabetic gastroparesis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Diabetic gastroparesis:

Cite this brief

Drug Landscape (2026). Diabetic gastroparesis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/diabetic-gastroparesis. Accessed 2026-06-10.

Diabetic gastroparesis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing